456 related articles for article (PubMed ID: 18226260)
1. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
[TBL] [Abstract][Full Text] [Related]
3. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.
Lin CY; Ström A; Vega VB; Kong SL; Yeo AL; Thomsen JS; Chan WC; Doray B; Bangarusamy DK; Ramasamy A; Vergara LA; Tang S; Chong A; Bajic VB; Miller LD; Gustafsson JA; Liu ET
Genome Biol; 2004; 5(9):R66. PubMed ID: 15345050
[TBL] [Abstract][Full Text] [Related]
4. Merging microarray data from separate breast cancer studies provides a robust prognostic test.
Xu L; Tan AC; Winslow RL; Geman D
BMC Bioinformatics; 2008 Feb; 9():125. PubMed ID: 18304324
[TBL] [Abstract][Full Text] [Related]
5. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
6. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
7. Portraits of breast cancer progression.
Dalgin GS; Alexe G; Scanfeld D; Tamayo P; Mesirov JP; Ganesan S; DeLisi C; Bhanot G
BMC Bioinformatics; 2007 Aug; 8():291. PubMed ID: 17683614
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.
Cheng C; Fu X; Alves P; Gerstein M
Genome Biol; 2009; 10(9):R90. PubMed ID: 19723326
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.
Nagahata T; Onda M; Emi M; Nagai H; Tsumagari K; Fujimoto T; Hirano A; Sato T; Nishikawa K; Akiyama F; Sakamoto G; Kasumi F; Miki Y; Tanaka T; Tsunoda T
Cancer Sci; 2004 Mar; 95(3):218-25. PubMed ID: 15016320
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
11. Integration of clinical and microarray data with kernel methods.
Daemen A; Gevaert O; De Moor B
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5411-5. PubMed ID: 18003232
[TBL] [Abstract][Full Text] [Related]
12. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks.
Gevaert O; De Smet F; Timmerman D; Moreau Y; De Moor B
Bioinformatics; 2006 Jul; 22(14):e184-90. PubMed ID: 16873470
[TBL] [Abstract][Full Text] [Related]
13. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
14. A robust meta-classification strategy for cancer diagnosis from gene expression data.
Alexe G; Bhanot G; Venkataraghavan B; Ramaswamy R; Lepre J; Levine AJ; Stolovitzky G
Proc IEEE Comput Syst Bioinform Conf; 2005; ():322-5. PubMed ID: 16447989
[TBL] [Abstract][Full Text] [Related]
15. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
16. A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression.
Zhang Y; Zhang J; Liu Z; Liu Y; Tuo S
Biochem Biophys Res Commun; 2015 Sep; 465(3):437-42. PubMed ID: 26282201
[TBL] [Abstract][Full Text] [Related]
17. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis discovery of tissue-specific DNA sequence motifs from mammalian gene expression data.
Huber BR; Bulyk ML
BMC Bioinformatics; 2006 Apr; 7():229. PubMed ID: 16643658
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of gene expression data: a predictor-based approach.
Fishel I; Kaufman A; Ruppin E
Bioinformatics; 2007 Jul; 23(13):1599-606. PubMed ID: 17463023
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
